In Turkey and other emerging pharmaceutical markets, governments are taking steps to bolster domestic production, such as by subjecting foreign-made drugs to separate certification inspections that slow the flow of imports, Pharmaceutical Executive magazine editor-in-chief William Looney writes. The average time for a new drug to get marketing approval in Turkey is 772 days, compared with about 200 days in the European Union, according to a trade association.

Full Story:

Related Summaries